Summary
Pregnant and nonpregnant rats were treated with 37.5 mg phenobarbital (PB) per kg body weight twice daily for 4 days. Pregnant rats were injected with PB from day 10 to day 13 and from day 17 to day 20 of gestation and were used for the experiments on day 14 or day 21, respectively. This treatment resulted in a 35% increase in liver weight in nonpregnant rats. The livers of pregnant rats weighed the same as the livers from PB-treated nonpregnant rats, and PB-treatment during gestation had only a small stimulatory effect on liver weight.—The duration of sleeping time after an i.p. injection of 125 mg hexobarbital per kg maternal body weight was identical in control nonpregnant and control pregnant rats. PB-treatment significantly reduced the sleeping time but PB-treated pregnant rats had a longer sleeping time than PB-treated nonpregnant rats.—In liver microsomes, the K m and V max values were measured for the ethylmorphine N-demethylase and benzo(a)pyrene hydroxylase. For the two substrates the K m values were identical in all groups. The V max values for the two enzyme activities were not different in control pregnant and control nonpregnant rats when calculated per total liver. Treatment of the rats with PB increased the V max values for the two enzyme activities, but these values were significantly lower in the microsomes obtained from PB-treated pregnant rats.—The content of cytochrome P-450 was higher in PB-treated nonpregnant rats than in control nonpregnant rats, but no increase in the amount of cytochrome P-450 was measured after treating pregnant rats with PB.—The electron microscopic examination of the livers of pregnant rats revealed that the smooth elements of the endoplasmic reticulum were predominant in the cytoplasm, and after PB-treatment the typical proliferation of the smooth ER was not detectable.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- PB:
-
Phenobarbital
- BP:
-
Benzo(a)pyrene
- ER:
-
endoplasmic reticulum; day 14 or day 21 refer to day 14 of gestation or to day 21 of gestation, respectively
- N.P.:
-
nonpregnant
- CO:
-
control
References
Alvares, A. P., Mannering, G. J.: Two substrate kinetics of drug-metabolizing enzyme systems of hepatic microsomes. Molec. Pharmacol. 6, 206–212 (1970)
Bokelmann, O., Scheringer, W.: Gewicht und Stickstoffgehalt der Schwangerschaftsleber und ihre Beziehungen zur Frage der Arbeitshypertrophie. Arch. Gynäk. 150, 247–256 (1932)
Conney, A. H.: Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19, 317–366 (1967)
Conney, A. H., Burns, J. J.: Factors influencing drug metabolism. In: Advances in Pharmacology, Vol. I, pp. 31–58, S. Garattini, P. A. Shore, eds. New York: Academic Press 1962
Conney, A. H., Jacobson, M., Levin, W., Schneidman, K., Kuntzman, R.: Decreased central depressant effect of progesterone and other steroids in rats pretreated with drugs and insecticides. J. Pharmacol. exp. Ther. 154, 310–318 (1966)
Conney, A. H., Kuntzman, R.: Metabolism of normal body constituents by drug metabolizing enzymes in liver microsomes. In: Handbook of Pharmacology, Vol. XXVIII, Part 2, pp. 401–421, B. B. Brodie, J. R. Gillette and, H. S. Ackerman, eds. Berlin-Heidelberg-New York: Springer 1971
Conney, A. H., Lu, A. Y. H., Levin, W.,Somogyi, A., West, S., Jacobson, M. Ryan, D., Kuntzman, R.: Effect of enzyme inducers on substrate specificity of the cytochrome P-450's. Drug Metabolism and disposition 1, 199–210 (1973)
Cornall, A. G., Bardawill, C. J., David, M. M.: Determination of serum proteins by means of the biuret reaction. J. biol. Chem. 177, 751–766 (1949)
Fouts, J. R., Rogers, L. A.: Morphological changes in the liver accompanying stimulation of microsomal drug metabolizing enzyme activity by phenobarbital, chlordane, benzpyrene or methylcholanthrene in rats. J. Pharmacol. exp. Ther. 147, 112–119 (1965)
Franke, H., Klinger, W.: Untersuchungen zum Mechanismus der Enzyminduktion. Acta biol. med. germ. 17, 507–526 (1966)
Guarino, A. M., Gram, T. E., Schroeder, D. H., Call, J. B., Gillette, J.: Alterations in the kinetic constants for hepatic microsomal aniline hydroxylase and ethylmorphine N-demethylase associated with pregnancy in rats. J. Pharmacol. exp. Ther. 168, 224–228 (1969)
King, J. E., Becker, R. F.: Sex differences in the response of rats to pentobarbital sodium. Amer. J. Obstet. Gynec. 86, 856–864 (1963)
Kuntzman, R., Mark, L. C., Brand, L., Jacobson, M., Levin, W., Conney, A. H.: Metabolism of drugs and carcinogens by human liver enzymes. J. Pharmacol. exp. Ther. 152, 151–156 (1966)
Langecker, H.: Geschlechtsdifferenzen von Enzymaktivitäten in verschiedenen Organen. Arzneimittel-Forsch. 19, 1769–1777 (1969)
Levin, W., Welch, R. M., Conney, A. H.: Effect of phenobarbital and other drugs on the metabolism and uterotropic action of estradiol-17 β and estrone. J. Pharmacol. exp. Ther. 159, 362–371 (1968)
Lu, A. Y. H., Levin, W., West, S. B., Jacobson, M., Ryan, D., Kuntzman, R., Conney, A. H.: Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrates. J. biol. Chem. 248, 456–460 (1973)
Nash, T.: The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem. J. 55, 416–421 (1953)
Neale, M. G., Parke, D. V.: Effects of pregnancy on the metabolism of drugs in the rat an rabbit. Biochem. Pharmacol. 22, 1451–1461 (1973)
Omura, T., Sato, R.: The carbon monoxide-binding pigments of liver microsomes. J. biol. Chem. 239, 2370–2378 (1964)
Remmer, H., Merker, H.-J.: Drug induced changes in the liver endoplasmic reticulum: association with drug metabolizing enzymes. Science 142, 1657–1658 (1963)
Remmer, H., Merker, H.-J.: Enzyminduction und Vermehrung von endoplasmatischem Reticulum in der Leberzelle während der Behandlung mit Phenobarbital (Luminal). Klin. Wschr. 41, 276–281 (1963)
Schlede, E.: Unpublished observations (1973)
Schlede, E., Merker, H.-J.: Effect of benzo(α)pyrene treatment on the benzo(α) pyrene hydroxylase activity in maternal liver, placenta, and fetus of the rat during day 13 to day 18 of gestation. Naunyn-Schmiedeberg's Arch. Pharmacol. 272, 89–100 (1972)
Wattenberg, L. W., Leong, J. L., Strand, P. J.: Benzpyrene hydroxylase activity in the gastrointestinal tract. Cancer Res. 22, 1120–1125 (1962)
Welch, R. M., Gommi, B., Alvares, A., Conney, A. H.: Effect of enzyme induction on the metabolism of benzo(a)pyrene and 3′-methyl-4-monomethylaminoazobenzene in the pregnant and fetal rat. Cancer Res. 32, 973–978 (1972)
Wilkinson, G. N.: Statistical estimation in enzyme kinetics. Biochem. J. 80, 324–332 (1961)
Author information
Authors and Affiliations
Additional information
This work was supported by a grant from the Deutsche Forschungsgemeinschaft given to the Sonderforschungsbereich 29, “Embryonale Entwicklung und Differenzierung (Embryonal-Pharmakologie)”.
Rights and permissions
About this article
Cite this article
Schlede, E., Borowski, R. Decreased effect of phenobarbital treatment on microsomal drug metabolizing enzyme activity during gestation. Naunyn-Schmiedeberg's Arch. Pharmacol. 281, 341–355 (1974). https://doi.org/10.1007/BF00499430
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00499430